SCOPUS 정보 검색 플랫폼

Bioorganic and Medicinal Chemistry Letters

Volumn 11, Issue 17, 2001, Pages 2345-2349

New 1-aryl-4-(biarylmethylene)piperazines as potential atypical antipsychotics sharing dopamine D2-receptor and serotonin 5-HT1A-receptor affinities

(9) Feenstra, Rolf W a De Moes, Janpeter a Hofma, Jos J a Kling, Henk a Kuipers, Wilma a Long, Stephen K a Tulp, Martin Th M a Van der Heyden, Jan A M a Kruse, Chris G a

a Solvay Pharmaceuticals Inc (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLENE)PIPERAZINE DERIVATIVE; CHLORPROMAZINE; CLOZAPINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; RISPERIDONE; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; DOPAMINERGIC ACTIVITY; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; EXTRAPYRAMIDAL SYMPTOM; IN VIVO STUDY; REACTION ANALYSIS;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANTIPSYCHOTIC AGENTS; APOMORPHINE; BEHAVIOR, ANIMAL; BENZOXAZOLES; DOPAMINE ANTAGONISTS; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; MICE; PIPERAZINES; RATS; RECEPTORS, DOPAMINE D2; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SPIPERONE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0035801722 PISSN: 0960894X EISSN: None Source Type: Journal
DOI: 10.1016/S0960-894X(01)00425-5 Document Type: Article

Times cited : (52)

References (16)

1
- 0031962988
- (1998) Eur. Neuropsychopharmacol. , vol.8 , pp. 33
- King, D.J.¹

2
- 0030691208
- (1997) Psychiatry Res. , vol.72 , pp. 161
- Galletly, C.A.¹ Clark, C.R.² McFarlane, A.C.³ Weber, D.L.⁴

3
- 0029763907
- (1996) Neurosci. Behav. Rev. , vol.20 , pp. 325
- Wadenberg, M.-L.¹

4
- 0024478413
- (1989) Psychopharmacology , vol.97 , pp. 456
- Liebman, J.M.¹ Gerhardt, S.C.² Gerber, R.³

5
- 0028006302
- (1994) Eur. J. Neurosci. , vol.6 , pp. 1
- Ellenbroek, B.A.¹ Prinssen, E.P.M.² Cools, A.R.³

6
- 0023588163
- (1987) J. Med. Chem. , vol.30 , pp. 2099
- Van Wijngaarden, I.¹ Kruse, C.G.² Van Hes, R.³ Van der Heyden, J.A.M.⁴ Tulp, M.Th.M.⁵

7
- 0023676630
- (1988) J. Med. Chem. , vol.31 , pp. 1934
- Van Wijngaarden, I.¹ Kruse, C.G.² Van der Heyden, J.A.M.³ Tulp, M.Th.M.⁴

8
- 0003955223
- Patent WO97/36893, 1997
- (1997) Chem. Abstr. , vol.127 , pp. 331506
- Feenstra, R.W.¹ Kruse, C.G.² Tulp, M.Th.M.³ Kuipers, W.⁴ Long, S.K.⁵

9
- 0004133074
- Patent EP 0908458, 1999
- (1999) Chem. Abstr. , vol.130 , pp. 282087
- Feenstra, R.W.¹ Den Hartog, J.A.J.² Kruse, C.G.³ Tulp, M.Th.M.⁴ Long, S.K.⁵

10
- 0017625580
- (1977) Eur. J. Pharmacol. , vol.46 , pp. 377
- Creese, I.¹ Schneider, R.² Snyder, S.H.³

11
- 0021086972
- (1983) Nature , vol.305 , pp. 140
- Gozlan, H.¹ El Mestikawy, S.² Pichet, L.³ Glowinsky, J.⁴ Hamon, M.⁵

12
- 0017119483
- (1976) Psychopharmacology (Berlin) , vol.50 , pp. 1
- Protais, P.¹ Costentin, J.² Schwartz, J.C.³

13
- 0023689648
- (1988) Behav. Brain Res. , vol.31 , pp. 61
- Van der Heyden, J.A.M.¹ Bradford, D.²

14
- 0024471992
- (1989) Pharmacol. Biochem. Behav. , vol.33 , pp. 821
- Berendsen, H.H.G.¹ Jenck, F.² Broekkamp, C.L.E.³

15
- 15144346396
- (1998) J. Med. Chem. , vol.41 , pp. 1997
- Reitz, A.B.¹ Baxter, E.W.² Codd, E.E.³ Davis, C.B.⁴ Jordan, A.D.⁵ Maryanoff, B.E.⁶ Maryanoff, C.A.⁷ McDonnell, M.E.⁸ Powell, E.T.⁹ Renzi, M.J.¹⁰ Schott, M.R.¹¹ Scott, M.K.¹² Shank, R.P.¹³ Vaught, J.L.¹⁴

16
- 0003951933
- Patent EP 0900792, 1999
- (1999) Chem. Abstr. , vol.130 , pp. 223299
- Feenstra, R.W.¹ Visser, G.M.² Kruse, C.G.³ Tulp, M.Th.M.⁴ Long, S.K.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.